Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression inTransthyretin (ATTR) Amyloidosis
Consistently rapid, deep and durable reduction in serum TTR accompanied by evidence…
Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated…
Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024
Two New Analyses from SEQUOIA-HCM Demonstrate Treatment with Aficamten Improves Post-Exercise Oxygen…
VERSES Closes Second Tranche of LIFE Offering Bringing Aggregate Funds Raised to $5.2M From Recent Offerings
November 15, 2024 20:51 ET | Source: VERSES AI Inc. THIS NEWS…
Nvni Group Limited Receives Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Nvni Group Limited (Nasdaq:…
Update on the privatisation of Humo payments system in Uzbekistan
November 15, 2024 16:15 ET | Source: JSC Kaspi.kz ALMATY, Kazakhstan, Nov.…
AppTech Payments Reports Third Quarter 2024 Results and Provides Business Update
CARLSBAD, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (NASDAQ:…
$SINK Set to Disrupt the Meme Culture with Blockchain Technology.
Amsterdam, Netherlands, Nov. 15, 2024 (GLOBE NEWSWIRE) -- To address the latest…
Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab
November 16, 2024 02:53 ET | Source: Junshi Biosciences SHANGHAI, Nov. 16,…
Precede Biosciences Presents New Data at AACR LBx 2024 Demonstrating an Accurate Readout of Tumor PSMA Expression and Stratification of Response to Lutetium-PSMA in Men with mCRPC from a Simple Blood Test
Results show the potential of a real-time, non-invasive blood test to quantify…